Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 13Recruiting 5Unknown 1Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Genitourinary 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 27Carcinoma, Renal Cell 10Melanoma 4Breast Neoplasms 4Urinary Bladder Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Kidney Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Non-Small-Cell Lung 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Radiation Injuries 1Prostatic Hyperplasia 1Penile Neoplasms 1Osteosarcoma 1Nocturia 1Neuroendocrine Tumors 1Nephrolithiasis, Calcium Oxalate 1Multiple Myeloma 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Gastrointestinal Stromal Tumors × Genitourinary × Clear all
NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

DNAtrix, Inc.

Phase 1 Suspended
30 enrolled
BreastDermatologicGastrointestinalGenitourinarySarcoma

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡